Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Tyck till om SwePub Sök här!

Search: WFRF:(Lurie N) > Menopausal hormone ...

Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies

Gapstur, S. M. (author)

Patel, A. V. (author)

Banks, E. (author)

Dal Maso, L. (author)

Talamini, R. (author)

Chetrit, A. (author)

Hirsh-Yechezkel, G. (author)

Lubin, F. (author)

Sadetzki, S. (author)

Beral, V. (author)

Bull, D. (author)

Cairns, B. (author)

Crossley, B. (author)

Gaitskell, K. (author)

Goodill, A. (author)

Green, J. (author)

Hermon, C. (author)

Key, T. (author)

Moser, K. (author)

Reeves, G. (author)

Sitas, F. (author)

Collins, R. (author)

Peto, R. (author)

Gonzalez, C. A. (author)

Lee, N. (author)

Marchbanks, P. (author)

Ory, H. W. (author)

Peterson, H. B. (author)

Wingo, P. A. (author)

Martin, N. (author)

Silpisornkosol, S. (author)

Theetranont, C. (author)

Boosiri, B. (author)

Chutivongse, S. (author)

Jimakorn, P. (author)

Virutamasen, P. (author)

Wongsrichanalai, C. (author)

Goodman, M. T. (author)

Lidegaard, O. (author)

Kjaer, S. K. (author)

Morch, L. S. (author)

Kjaer, S. K. (author)

Tjonneland, A. (author)

Byers, T. (author)

Rohan, T. (author)

Mosgaard, B. (author)

Vessey, M. (author)

Yeates, D. (author)

Freudenheim, J. L. (author)

Titus, L. J. (author)

Chang-Claude, J. (author)

Kaaks, R. (author)

Anderson, K. E. (author)

Lazovich, D. (author)

Robien, K. (author)

Hampton, J. (author)

Newcomb, P. A. (author)

Rossing, M. A. (author)

Thomas, D. B. (author)

Weiss, N. S. (author)

Lokkegaard, E. (author)

Riboli, E. (author)

Clavel-Chapelon, F. (author)

Cramer, D. (author)

Hankinson, S. E. (author)

Tamimi, R. M. (author)

Tworoger, S. S. (author)

Franceschi, S. (author)

La Vecchia, C. (author)

Negri, E. (author)

Adami, H. O. (author): Karolinska Institutet

Magnusson, C. (author): Karolinska Institutet

Riman, T. (author)

Weiderpass, E. (author): Karolinska Institutet

Wolk, A. (author): Karolinska Institutet

Schouten, L. J. (author)

van den Brandt, P. A. (author)

Chantarakul, N. (author)

Koetsawang, S. (author)

Rachawat, D. (author)

Palli, D. (author)

Black, A. (author)

Brinton, L. A. (author)

Freedman, D. M. (author)

Hartge, P. (author)

Hsing, A. W. (author)

Jnr, J. V. Lacey (author)

Lissowska, J. (author)

Hoover, R. N. (author)

Schairer, C. (author)

Babb, C. (author)

Urban, M. (author)

Graff-Iversen, S. (author)

Selmer, R. (author)

Bain, C. J. (author)

Green, A. C. (author)

Purdie, D. M. (author)

Siskind, V. (author)

Webb, P. M. (author)

Moysich, K. (author)

McCann, S. E. (author)

Hannaford, P. (author)

Kay, C. (author)

Binns, C. W. (author)

Lee, A. H. (author)

Zhang, M. (author)

Ness, R. B. (author)

Nasca, P. (author)

Coogan, P. F. (author)

Palmer, J. R. (author)

Rosenberg, L. (author)

Whittemore, A. (author)

Katsouyanni, K. (author)

Trichopoulou, A. (author)

Trichopoulos, D. (author)

Tzonou, A. (author)

Dabancens, A. (author)

Martinez, L. (author)

Molina, R. (author)

Salas, O. (author)

Lurie, G. (author)

Carney, M. E. (author)

Wilkens, L. R. (author)

Werner Hartman, Linda (author): Lund University,Lunds universitet,Medicinsk onkologi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Medical oncology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine

Manjer, Jonas (author): Lund University,Lunds universitet,Kirurgi,Forskargrupper vid Lunds universitet,Surgery,Lund University Research Groups

Olsson, Håkan (author): Lund University,Lunds universitet,Medicinsk onkologi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Medical oncology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine

Kumle, M. (author)

Grisso, J. A. (author)

Morgan, M. (author)

Wheeler, J. E. (author)

Edwards, R. P. (author)

Kelley, J. L. (author)

Modugno, F. (author)

Onland-Moret, N. C. (author)

Peeters, P. H. M. (author)

Casagrande, J. (author)

Pike, M. C. (author)

Wu, A. H. (author)

Canfell, K. (author)

Miller, A. B. (author)

Gram, I. T. (author)

Lund, E. (author)

McGowan, L. (author)

Shu, X. O. (author)

Zheng, W. (author)

Farley, T. M. M. (author)

Holck, S. (author)

Meirik, O. (author)

Risch, H. A. (author)

show less...

(creator_code:org_t)

2015
2015
English.
In: The Lancet. - 1474-547X. ; 385:9980, s. 1835-1842

Related links:: https://portal.resea... (primary) (free); show more...; http://dx.doi.org/10... (free); https://lup.lub.lu.s...; https://doi.org/10.1...; http://kipublication...; show less...

Journal article (peer-reviewed)

Abstract Subject headings

Background Half the epidemiological studies with information about menopausal hormone therapy and ovarian cancer risk remain unpublished, and some retrospective studies could have been biased by selective participation or recall. We aimed to assess with minimal bias the effects of hormone therapy on ovarian cancer risk. Methods Individual participant datasets from 52 epidemiological studies were analysed centrally. The principal analyses involved the prospective studies (with last hormone therapy use extrapolated forwards for up to 4 years). Sensitivity analyses included the retrospective studies. Adjusted Poisson regressions yielded relative risks (RRs) versus never-use. Findings During prospective follow-up, 12 110 postmenopausal women, 55% (6601) of whom had used hormone therapy, developed ovarian cancer. Among women last recorded as current users, risk was increased even with <5 years of use (RR 1.43, 95% CI 1.31-1.56; p<0.0001). Combining current-or-recent use (any duration, but stopped <5 years before diagnosis) resulted in an RR of 1.37 (95% CI 1.29-1.46; p<0.0001); this risk was similar in European and American prospective studies and for oestrogen-only and oestrogen-progestagen preparations, but differed across the four main tumour types (heterogeneity p<0.0001), being definitely increased only for the two most common types, serous (RR 1.53, 95% CI 1.40-1.66; p<0.0001) and endometrioid (1.42, 1.20-1.67; p<0.0001). Risk declined the longer ago use had ceased, although about 10 years after stopping long-duration hormone therapy use there was still an excess of serous or endometrioid tumours (RR 1.25, 95% CI 1.07-1.46, p=0.005). Interpretation The increased risk may well be largely or wholly causal; if it is, women who use hormone therapy for 5 years from around age 50 years have about one extra ovarian cancer per 1000 users and, if its prognosis is typical, about one extra ovarian cancer death per 1700 users.

Find in a library

The Lancet (Search for host publication in LIBRIS)

To the university's database

Find more in SwePub

By the author/editor: Gapstur, S. M.; Patel, A. V.; Banks, E.; Dal Maso, L.; Talamini, R.; Chetrit, A.; show more...; Hirsh-Yechezkel, ...; Lubin, F.; Sadetzki, S.; Beral, V.; Bull, D.; Cairns, B.; Crossley, B.; Gaitskell, K.; Goodill, A.; Green, J.; Hermon, C.; Key, T.; Moser, K.; Reeves, G.; Sitas, F.; Collins, R.; Peto, R.; Gonzalez, C. A.; Lee, N.; Marchbanks, P.; Ory, H. W.; Peterson, H. B.; Wingo, P. A.; Martin, N.; Silpisornkosol, ...; Theetranont, C.; Boosiri, B.; Chutivongse, S.; Jimakorn, P.; Virutamasen, P.; Wongsrichanalai, ...; Goodman, M. T.; Lidegaard, O.; Kjaer, S. K.; Morch, L. S.; Tjonneland, A.; Byers, T.; Rohan, T.; Mosgaard, B.; Vessey, M.; Yeates, D.; Freudenheim, J. ...; Titus, L. J.; Chang-Claude, J.; Kaaks, R.; Anderson, K. E.; Lazovich, D.; Robien, K.; Hampton, J.; Newcomb, P. A.; Rossing, M. A.; Thomas, D. B.; Weiss, N. S.; Lokkegaard, E.; Riboli, E.; Clavel-Chapelon, ...; Cramer, D.; Hankinson, S. E.; Tamimi, R. M.; Tworoger, S. S.; Franceschi, S.; La Vecchia, C.; Negri, E.; Adami, H. O.; Magnusson, C.; Riman, T.; Weiderpass, E.; Wolk, A.; Schouten, L. J.; van den Brandt, ...; Chantarakul, N.; Koetsawang, S.; Rachawat, D.; Palli, D.; Black, A.; Brinton, L. A.; Freedman, D. M.; Hartge, P.; Hsing, A. W.; Jnr, J. V. Lacey; Lissowska, J.; Hoover, R. N.; Schairer, C.; Babb, C.; Urban, M.; Graff-Iversen, S ...; Selmer, R.; Bain, C. J.; Green, A. C.; Purdie, D. M.; Siskind, V.; Webb, P. M.; Moysich, K.; McCann, S. E.; Hannaford, P.; Kay, C.; Binns, C. W.; Lee, A. H.; Zhang, M.; Ness, R. B.; Nasca, P.; Coogan, P. F.; Palmer, J. R.; Rosenberg, L.; Whittemore, A.; Katsouyanni, K.; Trichopoulou, A.; Trichopoulos, D.; Tzonou, A.; Dabancens, A.; Martinez, L.; Molina, R.; Salas, O.; Lurie, G.; Carney, M. E.; Wilkens, L. R.; Werner Hartman, ...; Manjer, Jonas; Olsson, Håkan; Kumle, M.; Grisso, J. A.; Morgan, M.; Wheeler, J. E.; Edwards, R. P.; Kelley, J. L.; Modugno, F.; Onland-Moret, N. ...; Peeters, P. H. M ...; Casagrande, J.; Pike, M. C.; Wu, A. H.; Canfell, K.; Miller, A. B.; Gram, I. T.; Lund, E.; McGowan, L.; Shu, X. O.; Zheng, W.; Farley, T. M. M.; Holck, S.; Meirik, O.; Risch, H. A.; show less...

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Cancer and Oncol ...

Articles in the publication: The Lancet

By the university: Lund University; Karolinska Institutet

Search outside SwePub

Extend your search to:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se

Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies

Subject headings

Publication and Content Type

Find in a library

To the university's database

Find more in SwePub

Search outside SwePub